Your shopping cart is currently empty

HAA-09, an orally administered compound, serves as a powerful anti-influenza agent by targeting the influenza PB2_cap binding domain. It possesses significant activity against influenza A virus, exhibiting an EC50 of 0.03 μM, and demonstrates polymerase inhibition with an IC50 of 0.06±0.004 μM. Importantly, HAA-09 inhibits virus replication efficiently without inducing noticeable cytotoxicity [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | HAA-09, an orally administered compound, serves as a powerful anti-influenza agent by targeting the influenza PB2_cap binding domain. It possesses significant activity against influenza A virus, exhibiting an EC50 of 0.03 μM, and demonstrates polymerase inhibition with an IC50 of 0.06±0.004 μM. Importantly, HAA-09 inhibits virus replication efficiently without inducing noticeable cytotoxicity [1]. |
| Molecular Weight | 376.36 |
| Formula | C17H18F2N6O2 |
| Cas No. | 1422051-33-9 |
| Smiles | FC=1C=C2C(=CNC2=NC1)C=3NC(=NN(CC(O)=O)C(C)(C)C)C(F)=CN3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.